CD8A and neoplasm: Importantly, we found an intermediate transition cell population with specifically high expression of polyfunctional effector properties and cytolytic capacities in this evolutionary trajectory, which was consistent with previous studies showing that intratumoral stem-like CD8+ Tpex differentiated into temporary effector CD8+ T cells in response to vaccination or ICBs to promote tumor control25.